全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 148345-64-6 | 2-Ethoxy-1-naphthaleneboronic acid;2-Ethoxy-1-naphthylboronic acid | C12H13BO3 |
| 148347-90-4 | Dichlorobis[(1,2,3,3a,7a-H)-1-[5-Methyl-2-(1-Methylethyl)Cyclohexyl]-1H-Inden-1-Yl]-Zirconium Stereoisomer;(+)-BIS[1-[(1'R,2'R,5'R)-2'-I-PROPYL-5'-METHYLCYCLOHEXYL]INDENYL]ZIRCONIUM (IV) DICHLORIDE | C38H50Cl2Zr++ |
| 148355-75-3 | B-[3-[(Methylsulfonyl)Amino]Phenyl]-Boronic Acid;[3-(Methylsulfonylamino)Phenyl]Boronic Acid;3-Methanesulfonylaminophenylboronic Acid;Bm151 | C7H10BNO4S |
| 148356-06-3 | 4-(2-AMinoethyl)cyclohexanol | |
| 148356-14-3 | 8-Fluoro-2,4(1H,3H)-quinolinedione | C9H6FNO2 |
| 148367-89-9 | Ethyl (5Z)-4-(3-Chloro-4-Methylphenyl)-5-(Cyanoimino)-4,5-Dihydro-1,3,4-Thiadiazole-2-Carboxylate;dihydro-1,3,4-thiadiazole-2-carboxylate;Ethyl 4-(3-chloro-4-methylphenyl)-5-cyanamide-4,5-;Ethyl 4-(<wbr>3-chloro-<wbr>4-methylp<wbr>henyl)-5-<wbr>cyanamide<wbr>-4,5-dihy<wbr>dro-1,3,4<wbr>-thiadiaz<wbr>ole-2-car<wbr>boxylate | C13H11ClN4O2S |
| 148367-91-3 | (5Z)-N-(2-Chlorophenyl)-5-(Cyanoimino)-4-[4-(2-Methyl-2-Propanyl)Phenyl]-4,5-Dihydro-1,3,4-Thiadiazole-2-Carboxamide;4-(4-tert<wbr>-butylphe<wbr>nyl)-N-(2<wbr>-chloroph<wbr>enyl)-5-(<wbr>cyanoimin<wbr>o)-4,5-di<wbr>hydro-1,3<wbr>,4-thiadi<wbr>azole-2-c<wbr>arboxamide;4-(4-tert-Butylphenyl)-N-(2-chlorophenyl)-5-cyan-;amide-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide | C20H18ClN5OS |
| 148369-91-9 | (S)-Daipen;(2S)-(+)-1,1-Bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine | C19H26N2O2 |
| 148401-38-1 | 8-Fluoro-4-Quinolinamine;8-fluoro-4-quinolinamine;8-fluoro-4-quinolylamine;8-Fluoro-quinolin-4-ylamine | C9H7FN2 |
| 148404-28-8 | 5-Oxohexahydrocyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester | C12H19NO3 |
| 148404-29-9 | Hexahydro-5-oxocyclopenta[c]pyrrole-2(1H)-carboxylic acid benzyl ester | C15H17NO3 |
| 148408-65-5 | 1-[[(7S,9aS)-2-Pyrimidin-2-Yl-1,3,4,6,7,8,9,9a-Octahydropyrido[1,6-a]Pyrazin-7-Yl]Methyl]Pyrrolidine-2,5-Dione Hydrochloride;1-[[(7S,9As)-2-(2-Pyrimidinyl)-1,3,4,6,7,8,9,9A-Octahydropyrido[1,6-A]Pyrazin-7-Yl]Methyl]Pyrrolidine-2,5-Dione Hydrochloride;1-[[(7S,9As)-2-(2-Pyrimidyl)-1,3,4,6,7,8,9,9A-Octahydropyrido[1,6-A]Pyrazin-7-Yl]Methyl]Pyrrolidine-2,5-Quinone Hydrochloride;D02569 | C17H24ClN5O2 |
| 148408-66-6 | Docetaxel trihydrate | C43H53NO14.3(H2O) |
| 148409-20-5 | (9Z,17S)-17-[[6-O-Acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy]-9-octadecenoic acid intramol. 1,4''-ester;2,5-Ethano-7H,26H-pyrano[3,2-d]-1,3,6,24-tetraoxacyclohexacosin | C34H56O14 |
| 148409-36-3 | (+)-Matairesinol;(2S,3S)-2alpha-(4''-Hydroxy-3''-methoxybenzyl)-3beta-(4'-hydroxy-3'-methoxybenzyl)-gamma-butyrolactone | C20H22O6 |
| 148411-57-8 | Chitosan lactate (ester);Chitosan 2-hydroxypropanoate (ester) | |
| 148416-38-0 | 2,3,4-Trifluoro-6-nitroaniline;6-Nitro-2,3,4-trifluoroaniline | C6H3F3N2O2 |
| 148432-44-4 | (1R,4S)-Bicyclo[2.2.1]Hept-2-Yl[(1S,4R)-Bicyclo[2.2.1]Hept-2-Yl]Phosphine;DI-2-NORBORNYLPHOSPHINE | C14H23P |
| 148436-13-9 | 4-(Aminomethyl)-1-(4-Methoxyphenyl)Pyrrolidin-2-One;4-(Aminomethyl)-1-(4-Methoxyphenyl)-2-Pyrrolidinone;4-(Aminomethyl)-1-(4-Methoxyphenyl)-2-Pyrrolidone;2-Pyrrolidinone, 4-Aminomethyl-1-(4-Methoxyphenyl)- | C12H16N2O2 |
| 148436-63-9 | AH 13205 | C24H36O4 |
| 148437-99-4 | Methyl 2-(Trifluoromethoxy)Benzoate;2-(Trifluoromethoxy)benzoic acid methyl ester;6-Nitro-2,3,4-trifluoroaniline;Methyl 2-(trifluoromethoxy)benzoate 97% | C9H7F3O3 |
| 148438-00-0 | Methyl 3-(trifluoromethoxy)benzoate | C9H7F3O3 |
| 148439-49-0 | 106-126-Prion protein (human);06-126-Prion protein (synthetic fragment PrP106-126); 106-126-Prion protein PrP (synthetic) | C80H138N26O24S2 |
| 148440-73-7 | L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-arginylglycylglycyl-L-Lysine cyclic (1->6)-disulfide;1-{[(4R,7<wbr>S,10S,13S<wbr>,16S,19R)<wbr>-19-Amino<wbr>-7-(2-ami<wbr>no-2-oxoe<wbr>thyl)-10-<wbr>(3-amino-<wbr>3-oxoprop<wbr>yl)-13-[(<wbr>2S)-2-but<wbr>anyl]-16-<wbr>(4-hydrox<wbr>ybenzyl)-<wbr>6,9,12,15<wbr>,18-penta<wbr>oxo-1,2-d<wbr>ithia-5,8<wbr>,11,14,17<wbr>-pentaaza<wbr>cycloicos<wbr>an-4-yl]c<wbr>ar bonyl}<wbr>-L-prolyl<wbr>-L-arginy<wbr>lglycylgl<wbr>ycyl-L-ly<wbr>sin;1-{[(4R,7<wbr>S,10S,13S<wbr>,16S,19R)<wbr>-19-Amino<wbr>-7-(2-ami<wbr>no-2-oxoe<wbr>thyl)-10-<wbr>(3-amino-<wbr>3-oxoprop<wbr>yl)-13-[(<wbr>2S)-2-but<wbr>anyl]-16-<wbr>(4-hydrox<wbr>ybenzyl)-<wbr>6,9,12,15<wbr>,18-penta<wbr>oxo-1,2-d<wbr>ithia-5,8<wbr>,11,14,17<wbr>-pentaaza<wbr>cycloicos<wbr>an-4-yl]c<wbr>ar bonyl}<wbr>-L-prolyl<wbr>-L-arginy<wbr>lglycylgl<wbr>ycyl-L-ly<wbr>sine;1-{[(4R,7<wbr>S,10S,13S<wbr>,16S,19R)<wbr>-19-Amino<wbr>-7-(2-ami<wbr>no-2-oxoé<wbr>thyl)-10-<wbr>(3-amino-<wbr>3-oxoprop<wbr>yl)-13-[(<wbr>2S)-2-but<wbr>anyl]-16-<wbr>(4-hydrox<wbr>ybenzyl)-<wbr>6,9,12,15<wbr>,18-penta<wbr>oxo-1,2-d<wbr>ithia-5,8<wbr>,11,14,17<wbr>-pentaaza<wbr>cycloicos<wbr>an-4-yl]c<wbr>ar bonyl}<wbr>-L-prolyl<wbr>-L-arginy<wbr>lglycylgl<wbr>ycyl-L-ly<wbr>sine | C51H81N17O15S2 |
| 148440-81-7 | N-Cyclohexyl-4-(1H-Imidazol-5-Yl)-1-Piperidinecarbothioamide (2Z)-2-Butenedioate (1:1);[106243-16-7];N-Cyclohe<wbr>xyl-4-(1H<wbr>-imidazol<wbr>-4-yl)-1-<wbr>piperidin<wbr>ecarbothi<wbr>oamide ma<wbr>leate salt;N-cyclohe<wbr>xyl-4-(1H<wbr>-imidazol<wbr>-5-yl)-(2<wbr>Z)-2-bute<wbr>nedioate-<wbr>1-piperid<wbr>inecarbot<wbr>hioamide | C19H28N4O4S |
| 148459-00-1 | 4-(Bromomethyl)-N-methylbenzenesulfonamide | C8H10BrNO2S |
| 148459-54-5 | 4-Amino-3-methoxyphenylmethanol;[4-Amino-3-(methyloxy)phenyl]methanol | C8H11NO2 |
| 148461-14-7 | (4S)-2-(2-(Diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole;diphenyl-[2-[(4S)-4-propan-2-yl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]phosphane | C24H24NOP |
| 148461-16-9 | (4S)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole | C25H26NOP |
| 148476-30-6 | 4-Hydroxy-3-Mesityl-1-Oxaspiro[4.4]Non-3-En-2-One;4-Hydroxy-3-mesityl-1-oxaspiro non-3-en-2-one | C17H20O3 |
| 148477-71-8 | Spirodiclofen;[3-(2,4-Dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl] 2,2-dimethylbutanoate | C21H24Cl2O4 |
| 148490-97-5 | 4-Iodo-2-Methoxy-Benzoic Acid Methyl Ester;Methyl 4-Iodo-2-Methoxybenzoate, 98+%;METHYL 4-IODO-2-METHOXYBENZOATE | C9H9IO3 |
| 148493-34-9 | 2,6-Dichloropyridine-3-boronic acid | C5H4BCl2NO2 |
| 148493-37-2 | 2,6-Dichloro-3-iodopyridine | C5H2Cl2IN |
| 148494-90-0 | 1-Phenylpiperidin-3-one;1-Phenyl-3-piperidinone | C11H13NO |
| 148494-98-8 | 4b1,5,10,15-Tetraazanaphtho[1,2,3-gh]tetraphene-2,3,7,8,12,13-hexaol | C21H12N4O6 |
| 148498-78-6 | Adrenomedullin (Human) | |
| 148504-34-1 | Cellstain Calcein-AM;Calcein O,O'-diacetate tetrakis(acetoxymethyl)ester | C46H46N2O23 |
| 148505-45-7 | 4-(4-Nitrophenoxy)-Piperidine Hydrochloride (1:1);4-(4-NITRO-PHENOXY)-PIPERIDINE HYDROCHLORIDE;4-(4'-NITROPHENOXY)PIPERIDINE HYDROCHLORIDE | C11H15ClN2O3 |
| 148515-78-0 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-[(2-hydroxy-4-methoxyphenyl)methyl]glycine | C25H23NO6 |
| 148516-11-4 | Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate ;2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylic acid ethyl ester | C21H18FNO2 |
| 148516-15-8 | Pitavastatin Impurity 29;(2S)-2-[(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]ethenyl]-2,3-dihydropyran-6-one | C25H20FNO2 |
| 148533-73-7 | 6-Nitro-2-(4-Pyridinyl)-1H-Benzimidazole;5-NITRO-2-(4-PYRIDINYL)-1H-BENZIMIDAZOLE;5-NITRO-2-PYRIDIN-4-YL-1H-BENZIMIDAZOLE;5-NITRO-2-(4-PYRIDYL)BENZIMIDAZOLE | C12H8N4O2 |
| 148541-70-2 | 5-Fluoropyridine-2-carboxylic acid ethyl ester;Ethyl 5-fluoropyridine-2-carboxylate | C8H8FNO2 |
| 148546-82-1 | 4-Methylpyridine-3-boronic acid | C6H8BNO2 |
| 148546-97-8 | 1-Methyl-4-(3-nitrophenyl)piperazine | C11H15N3O2 |
| 148546-99-0 | 3-(4-Methylpiperazin-1-yl)aniline | C11H17N3 |
| 148547-19-7 | Methyl 4-bromo-3-methylbenzoate | C9H9BrO2 |
| 148550-51-0 | Ethyl 2-(Methylsulfonyl)-5-Pyrimidinecarboxylate;ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate;ethyl-2-(methylsulfonyl)pyrimidine-5-carboxylate;MFCD07366751 | C8H10N2O4S |
| 148553-50-8 | Pregabalin;3-(Aminomethyl)-5-methyl-hexanoic acid | C8H17NO2 |